Complex interactions and composite burden of risk factors in vascular cognitive impairment

Linna Ji1, Junjian Zhang1

  • 1Department of Neurology, Zhongnan Hospital of Wuhan University, Wuhan, China.

PubMed

Insights

Managing vascular risk factors (VRFs) is key for vascular cognitive impairment (VCI). This review explores complex interactions among VRFs and their impact on VCI, highlighting the need for comprehensive strategies beyond single-factor management.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Gerontology

Background:

  • Vascular cognitive impairment (VCI) encompasses a spectrum of cognitive decline linked to vascular factors.
  • Current management focuses on symptomatic treatment and addressing individual vascular risk factors (VRFs).
  • Managing single VRFs is insufficient due to VCI's complexity and the impact of combined risk factors.

Purpose of the Study:

  • To review clinical evidence on complex interactions among VRFs in VCI.
  • To explore the implications of these interactions for VCI progression and prevention.
  • To summarize current risk assessment tools and suggest future research directions.

Main Methods:

  • Literature review of clinical evidence on VCI and VRF interactions.
  • Analysis of studies investigating combinations of VRFs and their impact on cognitive decline.
  • Summary of existing and novel risk prediction models for VCI.

Main Results:

  • VCI management requires addressing complex interactions among multiple VRFs, not just individual factors.
  • Understanding comorbid VRF effects is crucial for identifying at-risk populations.
  • Various risk scores and models, including AI-driven ones, are used for VCI risk evaluation.

Conclusions:

  • Comprehensive strategies targeting combined VRFs are essential for VCI prevention and management.
  • Further research is needed to refine risk profiling, develop effective risk scores, and implement targeted interventions.
  • Identifying specific clinical risk profiles can improve VCI risk prediction and prevention efforts.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
94
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
50
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
25
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
162